News

An increasingly studied adjunctive therapy is Hyaluronic Acid, known for its hydrating, regenerative, and anti-inflammatory properties.

Beyond clinical outcomes, the simultaneous approach offered additional benefits: reduced overall treatment time and higher patient satisfaction.

A newly recognised subtype of Castleman disease (CD), termed oligocentric CD (OligoCD), has been identified and characterised through the ACCELERATE natural history registry….

Discover a recent study that has provided crucial new insights into the treatment of upper tract urothelial carcinoma.

New data reveal that acute pulmonary embolism, though rare in children and adolescents, carries a significant risk of death.

Understand how preoperative MRI does not boost survival in HER2-positive, HR-negative breast cancer

Discover how psilocybin therapy could transform Parkinson’s care – read more about this promising pilot trial and future directions.

A new study from the COMBI-AD trial shows that circulating tumour DNA (ctDNA) testing can accurately predict recurrence and survival in stage III melanoma, offering a potential tool for personalising treatment.